Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy

Details for Australian Patent Application No. 2009217031 (hide)

Owner Laboratorios Del Dr. Esteve, S.A.

Inventors Buschmann, Helmut H.; ZamanilloCastanedo, Daniel; Vela-Hernandez, Jose-Miguel; Nieto-Lopez, Francisco Rafael; Baeyens-Cabrera, Jose Manuel

Agent Shelston IP

Pub. Number AU-A-2009217031

PCT Pub. Number WO2009/103487

Priority 08384001.7 18.02.08 EP; 08008682.0 08.05.08 EP

Filing date 17 February 2009

Wipo publication date 27 August 2009

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 29/02 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/103487 Priority application(s): WO2009/103487

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009217042-A spray dryer absorber disperser arrangement

2009217028-SGK1 inhibitors for the prophylaxis and/ or therapy of viral diseases and/or carcinomas